Levonorgestrel 52mg IUS Study

Reclaiming Your Life From Heavy Periods

Heavy menstrual bleeding (clinical term: menorrhagia) is not just an inconvenience. For many women, it dictates what clothes they can wear, disrupts plans, drains their energy, and compromises their overall health by causing anemia. Yet, far too often, women are told that heavy periods are just "something they have to deal with."

At MomDoc Women's Health Research, we believe that treating heavy bleeding shouldn't require major, invasive surgery.

That's why our research center is evaluating an investigational approach using a specialized, hormone-releasing intrauterine system (IUS).

The Science of Targeted Treatment

This Phase 3, open-label study is rigorously evaluating how well this device performs. According to the official clinical trial documentation, the goal is targeted and precise:

"To assess the efficacy of a levonorgestrel 52 mg intrauterine system as a treatment for heavy menstrual bleeding."

While similar intrauterine devices exist to prevent pregnancy, the primary focus of this trial is on proving its effectiveness and safety as a dedicated, targeted medical treatment for excessive bleeding. Rather than systemic medications, an IUS delivers treatment directly where it's needed.

Who Can Participate?

When you participate in this study, you receive close monitoring from our expert clinical team while actively helping to establish better care guidelines for a condition that affects millions of women. We are looking for women (ages 18-50) who meet the following key criteria:

You experience abnormally heavy or prolonged menstrual bleeding.
You are seeking a non-surgical treatment option.
Certain anatomical conditions (such as specific types of large fibroids) may exclude participation, to be determined during a private screening.

Participation in MomDoc clinical trials is always voluntary, always free, and often includes compensation for time and travel.